• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2400180 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
JYSB2400182 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
JYSB2400181 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
JYSB2400179 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
JYSB2400155 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
JYSB2400156 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
JYSB2400157 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
JYSB2400158 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
CYSB2400133 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-05-24 SinoCelltech Ltd view
CYSB2400134 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-05-24 SinoCelltech Ltd view
CYSB2400087 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2024-04-09 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CXSL2400210 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) New Drug Application 2024-04-03 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CXSB2400019 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-09 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JYSB2400051 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-07 view
JYSB2400050 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-07 view
JYSB2400048 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-07 view
JYSB2400049 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-07 view
JYSB2300183 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-10-26 view
JYSB2300181 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-10-26 view
JYSB2300180 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-10-26 view